NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

EPA:ALNXT • FR0004171346

0.398 EUR
+0.01 (+2.05%)
Last: Feb 26, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALNXT. ALNXT was compared to 65 industry peers in the IT Services industry. While ALNXT seems to be doing ok healthwise, there are quite some concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALNXT.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ALNXT had positive earnings in the past year.
  • ALNXT had a positive operating cash flow in the past year.
  • ALNXT had positive earnings in each of the past 5 years.
  • ALNXT had a positive operating cash flow in 4 of the past 5 years.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • ALNXT has a worse Return On Assets (2.83%) than 61.54% of its industry peers.
  • ALNXT has a worse Return On Equity (4.93%) than 63.08% of its industry peers.
  • ALNXT has a Return On Invested Capital of 6.30%. This is in the lower half of the industry: ALNXT underperforms 60.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALNXT is significantly below the industry average of 11.74%.
  • The last Return On Invested Capital (6.30%) for ALNXT is above the 3 year average (6.20%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROIC 6.3%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • ALNXT has a Profit Margin of 2.50%. This is comparable to the rest of the industry: ALNXT outperforms 41.54% of its industry peers.
  • ALNXT's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 5.15%, ALNXT is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ALNXT has declined.
  • ALNXT has a worse Gross Margin (54.19%) than 61.54% of its industry peers.
  • In the last couple of years the Gross Margin of ALNXT has declined.
Industry RankSector Rank
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ALNXT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ALNXT has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALNXT has more shares outstanding
  • Compared to 1 year ago, ALNXT has an improved debt to assets ratio.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 2.12 indicates that ALNXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ALNXT has a Altman-Z score of 2.12. This is comparable to the rest of the industry: ALNXT outperforms 43.08% of its industry peers.
  • The Debt to FCF ratio of ALNXT is 3.10, which is a good value as it means it would take ALNXT, 3.10 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.10, ALNXT is in line with its industry, outperforming 56.92% of the companies in the same industry.
  • A Debt/Equity ratio of 0.12 indicates that ALNXT is not too dependend on debt financing.
  • ALNXT has a Debt to Equity ratio of 0.12. This is in the better half of the industry: ALNXT outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Altman-Z 2.12
ROIC/WACC0.95
WACC6.65%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.25, ALNXT perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
  • ALNXT has a Quick Ratio of 1.25. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.25, ALNXT is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ALNXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.13%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 3.66% on average over the past years.
  • The Revenue has decreased by -2.25% in the past year.
  • Measured over the past years, ALNXT shows a very strong growth in Revenue. The Revenue has been growing by 21.48% on average per year.
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.47% on average over the next years. This is quite good.
  • ALNXT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.18% yearly.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • ALNXT is valuated reasonably with a Price/Earnings ratio of 9.95.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALNXT indicates a rather cheap valuation: ALNXT is cheaper than 89.23% of the companies listed in the same industry.
  • ALNXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.11.
  • The Price/Forward Earnings ratio is 4.29, which indicates a rather cheap valuation of ALNXT.
  • Based on the Price/Forward Earnings ratio, ALNXT is valued cheaper than 95.38% of the companies in the same industry.
  • ALNXT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.13.
Industry RankSector Rank
PE 9.95
Fwd PE 4.29
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 70.77% of the companies in the same industry are more expensive than ALNXT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.5
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.48
PEG (5Y)2.72
EPS Next 2Y9.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALNXT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEXTEDIA

EPA:ALNXT (2/26/2026, 7:00:00 PM)

0.398

+0.01 (+2.05%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap15.53M
Revenue(TTM)62.04M
Net Income(TTM)1.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.95
Fwd PE 4.29
P/S 0.25
P/FCF 8.5
P/OCF 8.12
P/B 0.49
P/tB 13.39
EV/EBITDA N/A
EPS(TTM)0.04
EY10.05%
EPS(NY)0.09
Fwd EY23.29%
FCF(TTM)0.05
FCFY11.76%
OCF(TTM)0.05
OCFY12.31%
SpS1.59
BVpS0.81
TBVpS0.03
PEG (NY)0.48
PEG (5Y)2.72
Graham Number0.85
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROCE 8.85%
ROIC 6.3%
ROICexc 7.81%
ROICexgc N/A
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
FCFM 2.94%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.14%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 117.82%
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 2.12
F-Score7
WACC6.65%
ROIC/WACC0.95
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.19%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.15%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y-33.49%
OCF growth 3Y-10.82%
OCF growth 5YN/A

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.


What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.


What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 3 / 10.


How financially healthy is NEXTEDIA?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.